NeOnc Technologies Holdings, Inc.

NeOnc Appoints Sidra Medicine CEO and Forbes Top 100 Healthcare Leader, Dr. Iyabo Tinubu-Karch, to Scientific Advisory Board

Los Angeles, CA, April 18, 2023 – NeOnc Technologies Holdings, Inc., a clinical-stage medical biotechnology company, has appointed Dr. Iyabo Tinubu-Karch to its scientific advisory board as a strategic advisor.   Dr. Iyabo Tinubu-Karch The company’s scientific advisory board, now comprised of five global healthcare leaders, provides NeOnc management with valuable guidance and perspectives on […]

NeOnc’s CEO, Thomas Chen, MD, Ph.D., Awarded American Health Council’s ‘Best in Medicine’

Los Angeles, CA, Chicago, IL, London, UK, April 4, 2023 – NeOnc Technologies Holdings Inc., a clinical-stage medical biotechnology company, announced that its CEO, Thomas Chen, MD, Ph.D., has received the Best in Medicine Award from the American Health Council (AHC). As a national collaboration for the advancement of healthcare, the AHC honors with this […]